Anthony Caracciolo - Net Worth and Insider Trading

Anthony Caracciolo Net Worth

The estimated net worth of Anthony Caracciolo is at least $12,603 dollars as of 2024-04-29. Anthony Caracciolo is the Director of CytoDyn Inc and owns about 88,136 shares of CytoDyn Inc (CYDY) stock worth over $12,603. Anthony Caracciolo is also the SVP, Manufacturing of Gilead Sciences Inc and owns about 0 shares of Gilead Sciences Inc (GILD) stock worth over $0. Details can be seen in Anthony Caracciolo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony Caracciolo has not made any transactions after 2014-10-30 and currently still holds the listed stock(s).

Transaction Summary of Anthony Caracciolo

To

Anthony Caracciolo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony Caracciolo owns 2 companies in total, including CytoDyn Inc (CYDY) , and Gilead Sciences Inc (GILD) .

Click here to see the complete history of Anthony Caracciolo’s form 4 insider trades.

Insider Ownership Summary of Anthony Caracciolo

Ticker Comapny Transaction Date Type of Owner
CYDY CytoDyn Inc 2014-10-30 director
GILD Gilead Sciences Inc 2005-11-22 SVP

Anthony Caracciolo Latest Holdings Summary

Anthony Caracciolo currently owns a total of 2 stocks. Among these stocks, Anthony Caracciolo owns 88,136 shares of CytoDyn Inc (CYDY) as of October 30, 2014, with a value of $12,603 and a weighting of 100%. Anthony Caracciolo also owns 0 shares of Gilead Sciences Inc (GILD) as of November 22, 2005, with a value of $0 and a weighting of 0%.

Latest Holdings of Anthony Caracciolo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYDY CytoDyn Inc 2014-10-30 88,136 0.14 12,603
GILD Gilead Sciences Inc 2005-11-22 0 65.42 0

Holding Weightings of Anthony Caracciolo


Anthony Caracciolo Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony Caracciolo has made a total of 0 transactions in CytoDyn Inc (CYDY) over the past 5 years. The most-recent trade in CytoDyn Inc is the acquisition of 26,000 shares on October 30, 2014, which cost Anthony Caracciolo around $18,720.

According to the SEC Form 4 filings, Anthony Caracciolo has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 523,560 shares on November 22, 2005, which brought Anthony Caracciolo around $7 Million.

Insider Trading History of Anthony Caracciolo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony Caracciolo Trading Performance

GuruFocus tracks the stock performance after each of Anthony Caracciolo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Caracciolo is 7.94%. GuruFocus also compares Anthony Caracciolo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Caracciolo within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony Caracciolo's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony Caracciolo

Average Return

-21.87%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.76 7.94 -27.28 -21.87 -23.67 -19.27
Relative Return to S&P 500(%) 25.05 1.53 -32.85 -31.47 -35.75 -32.96

Anthony Caracciolo Ownership Network

Ownership Network List of Anthony Caracciolo

No Data

Ownership Network Relation of Anthony Caracciolo


Anthony Caracciolo Owned Company Details

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Anthony Caracciolo is the director of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytoDyn Inc Insider Transactions

No Available Data

Anthony Caracciolo Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony Caracciolo. You might contact Anthony Caracciolo via mailing address: 1111 Main Street, Suite 660, Vancouver Wa 98660.

Discussions on Anthony Caracciolo

No discussions yet.